Pulmonary pharmacology and therapeutics

Pulmonary pharmacology and therapeutics

TRIM33 prevents pulmonary fibrosis by impairing TGF-β1 signalling
Pierre-Marie Boutanquoi, Olivier Burgy, Guillaume Beltramo, Pierre-Simon Bellaye, Lucile Dondaine, Guillaume Marcion, Lenny Pommerolle, Aurélie Vadel, Maximilien Spanjaard, Oleg Demidov, Arnaud Mailleux, Bruno Crestani, Martin Kolb, Carmen Garrido, Françoise Goirand, Philippe Bonniaud

European Respiratory Journal Jun 2020, 55 (6) 1901346; DOI: 10.1183/13993003.01346-2019
Gefapixant in two randomised dose-escalation studies in chronic cough
Jaclyn A. Smith, Michael M. Kitt, Peter Butera, Steven A. Smith, Yuping Li, Zhi Jin Xu, Kimberley Holt, Shilpi Sen, Mandel R. Sher, Anthony P. Ford

European Respiratory Journal Mar 2020, 55 (3) 1901615; DOI: 10.1183/13993003.01615-2019
Respiratory adverse effects of opioids for breathlessness: a systematic review and meta-analysis
Cindy A. Verberkt, Marieke H.J. van den Beuken-van Everdingen, Jos M.G.A. Schols, Sushma Datla, Carmen D. Dirksen, Miriam J. Johnson, Sander M.J. van Kuijk, Emiel F.M. Wouters, Daisy J.A. Janssen

European Respiratory Journal Nov 2017, 50 (5) 1701153; DOI: 10.1183/13993003.01153-2017
Targeting fatty acid amide hydrolase as a therapeutic strategy for antitussive therapy
Michael A. Wortley, John J. Adcock, Eric D. Dubuis, Sarah A. Maher, Sara J. Bonvini, Isabelle Delescluse, Ross Kinloch, Gordon McMurray, Christelle Perros-Huguet, Marianthi Papakosta, Mark A. Birrell, Maria G. Belvisi

European Respiratory Journal Sep 2017, 50 (3) 1700782; DOI: 10.1183/13993003.00782-2017
New drug targets for chronic cough: research you can literally sink your teeth into!
Caroline J. Jolley, Surinder S. Birring

European Respiratory Journal Sep 2017, 50 (3) 1701571; DOI: 10.1183/13993003.01571-2017
Fooling the brain to alleviate dyspnoea
Capucine Morélot-Panzini

European Respiratory Journal Aug 2017, 50 (2) 1701383; DOI: 10.1183/13993003.01383-2017
Effect of the cooling sensation induced by olfactory stimulation by L-menthol on dyspnoea: a pilot study
Masashi Kanezaki, Satoru Ebihara

European Respiratory Journal Apr 2017, 49 (4) 1601823; DOI: 10.1183/13993003.01823-2016
Barriers to new drug development in respiratory disease
Peter J. Barnes, Sergio Bonini, Werner Seeger, Maria G. Belvisi, Brian Ward, Anthony Holmes

European Respiratory Journal May 2015, 45 (5) 1197-1207; DOI: 10.1183/09031936.00007915
Safety and pharmacokinetics of nintedanib and pirfenidone in idiopathic pulmonary fibrosis
Takashi Ogura, Hiroyuki Taniguchi, Arata Azuma, Yoshikazu Inoue, Yasuhiro Kondoh, Yoshinori Hasegawa, Masashi Bando, Shinji Abe, Yoshiro Mochizuki, Kingo Chida, Matthias Klüglich, Tsuyoshi Fujimoto, Kotaro Okazaki, Yusuke Tadayasu, Wataru Sakamoto, Yukihiko Sugiyama

European Respiratory Journal May 2015, 45 (5) 1382-1392; DOI: 10.1183/09031936.00198013
Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis
Lutz Wollin, Eva Wex, Alexander Pautsch, Gisela Schnapp, Katrin E. Hostettler, Susanne Stowasser, Martin Kolb

European Respiratory Journal May 2015, 45 (5) 1434-1445; DOI: 10.1183/09031936.00174914

Main menu

User menu

Search

Pulmonary pharmacology and therapeutics

Pages

Contact us